Why Cresco Stock May Be Poised to Take Off

Cresco Labs (OTC: CRLBF) is the fifth-largest public cannabis company by revenue, but there's plenty of potential for more growth in its business (and its share price). The company's stock is just over $12, still down from its 52-week high of $17.49.

The company's stock rose 5.67% on Thursday, May 27, after the company announced better-than-expected first-quarter earnings. Cresco's stock has risen more than 145% over the past 12 months and more than 20% this year. Here are a few reasons why I think it's about to go even higher. 

Image source: Getty Images.

Continue reading

Source Fool.com